|
|||||
|
|
Phase I study of oral CP-4126, a gemcitabine derivative, in patients with advanced solid tumors |
|
| Authors: | F. E. Stuurman E. E. Voest A. Awada P. O. Witteveen T. Bergeland P.-A. Hals W. Rasch J. H. M. Schellens A. Hendlisz |
| Affiliation: | 1. Division of Clinical Pharmacology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, the Netherlands 2. Department of Medical Oncology, University Medical Center, Utrecht, The Netherlands 4. Medical Oncology Clinic, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium 5. Clavis Pharma ASA, Oslo, Norway 3. Department of Pharmaceutical Sciences, Science Faculty, Utrecht University, Utrecht, The Netherlands |
| Abstract: | |
| Keywords: | |
| 本文献已被 SpringerLink 等数据库收录！ | |